US Patent 7541443 Anti-CD4 antibodies
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+332 characters)
Article
Patent abstract
Inducing tolerance in a primate by use of a compound, or a combination of at least two compounds, that has certain characteristics when tested in vitro. The compound, alone or in combination, is preferably TRX1 antibody and the compound or combination is preferably used in accordance with a specified dosing regimen.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07541443 Anti-CD4 antibodies US Patent 7541443 Anti-CD4 antibodies
Infobox
Patent Number
0754144300
Patent Number
754144300
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
075414430
Date of Patent
June 2, 2009
0Patent Application Number
103537080
Date Filed
January 29, 2003
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
075414430
Date of Patent
June 2, 2009
0Patent Application Number
103537080
Date Filed
January 29, 2003
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07541443 Anti-CD4 antibodies
Infobox
Is a
Patent jurisdiction
Patent number
07541443
Date of patent
June 2, 2009
Patent application number
10353708
Date Filed
January 29, 2003
Patent primary examiner
Find more entities like US Patent 7541443 Anti-CD4 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
